Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 15 de 15
Filter
1.
Rev. bras. oftalmol ; 80(1): 8-11, jan.-fev. 2021. graf
Article in Portuguese | LILACS | ID: biblio-1251324

ABSTRACT

RESUMO Objetivo: Avaliar a inibição da proliferação de fibroblastos in vitro das conjuntivas obtidas através de exérese de pterígios de pacientes utilizando mitomicina C (MMC) e ciclofosfamida (CF). Métodos: Os pterígios foram retirados de 7 pacientes e submetidos a cultivo celular. Após o cultivo, 3 fragmentos de dimensões iguais deste material foram colhidos de áreas adjacentes do pterígio removido de cada paciente. Eles foram randomicamente selecionados de tal forma que: um fragmento de cada paciente foi exposto: ao meio de cultura (grupo controle), a MMC e a CF por igual período de tempo nas concentrações de 0,4 mg/ml e 10 mg/ml respectivamente. Após este período realizou-se a contagem celular de fibroblastos destes 3 grupos. Cada grupo continha 7 fragmentos. Resultados: Com a utilização da MMC tivemos uma taxa de 95% da inibição da proliferação dos fibroblastos, enquanto com a CF 100%. Conclusões: Ambas as drogas apresentaram elevada taxa da inibição da proliferação de fibroblastos, porém a CF apresentou inibição maior que a MMC.


Abstract Objective: To evaluate the inhibition of fibroblast proliferation in vitro of conjunctiva obtained by excision of pterygium from patients using mitomycin (MMC) and cyclophosphamide (CF). Methods: Pterygiums were removed from 7 patients and subjected to cell culture. After cell cultivation, 3 fragments of equal dimensions of these tissues were collected from adjacent areas of each patient removed pterygium. They were randomly selected in such a way that one fragment of each patient was exposed to: the culture medium (group control), to MMC and to CF for an equal period of time at concentrations of 0,4 mg/dl and 10 mg/dl respectively. After this period, the fibroblast cell count of these groups were performed. Each group had seven fragments. Results: With the use of MMC we had a 95% rate of inhibition of fibroblast proliferation, while with CF 100%. Conclusion: Both drugs showed a high rate of inhibition of fibroblast proliferation, but CF showed greater inhibition than MMC.


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Wound Healing , Pterygium/surgery , Mitomycin/adverse effects , Cyclophosphamide/adverse effects , Cell Proliferation/physiology , Antimitotic Agents/adverse effects , Fibroblasts/physiology , In Vitro Techniques
2.
Clinics ; 73(supl.1): e813s, 2018. tab, graf
Article in English | LILACS | ID: biblio-974953

ABSTRACT

Cell cycle control genes are frequently mutated in cancer cells, which usually display higher rates of proliferation than normal cells. Dysregulated mitosis leads to genomic instability, which contributes to tumor progression and aggressiveness. Many drugs that disrupt mitosis have been studied because they induce cell cycle arrest and tumor cell death. These antitumor compounds are referred to as antimitotics. Vinca alkaloids and taxanes are natural products that target microtubules and inhibit mitosis, and their derivatives are among the most commonly used drugs in cancer therapy worldwide. However, severe adverse effects such as neuropathies are frequently observed during treatment with microtubule-targeting agents. Many efforts have been directed at developing improved antimitotics with increased specificity and decreased likelihood of inducing side effects. These new drugs generally target specific components of mitotic regulation that are mainly or exclusively expressed during cell division, such as kinases, motor proteins and multiprotein complexes. Such small molecules are now in preclinical studies and clinical trials, and many are products or derivatives from natural sources. In this review, we focused on the most promising targets for the development of antimitotics and discussed the advantages and disadvantages of these targets. We also highlighted the novel natural antimitotic agents under investigation by our research group, including combretastatins, withanolides and pterocarpans, which show the potential to circumvent the main issues in antimitotic therapy.


Subject(s)
Humans , Biological Products/chemistry , Antimitotic Agents/chemistry , Drug Development/methods , Antineoplastic Agents/chemistry , Biological Products/pharmacology , Antimitotic Agents/pharmacology , Mitosis/drug effects , Neoplasms/pathology , Neoplasms/drug therapy , Antineoplastic Agents/pharmacology
3.
Braz. j. biol ; 76(2): 520-525, Apr.-June 2016. tab
Article in English | LILACS | ID: lil-781411

ABSTRACT

Abstract The objective of this study was to evaluate the action of Hymenaea stigonocarpa bark hydroalcoholic extract against a mutagenic compound using A. cepa meristematic root cells as a test system. The treatment groups were: Negative Control (NC) – distilled water; Positive Control (PC) – paracetamol at a concentration of 0.008 mg/mL, Jatoba Control (JC) – aqueous fraction jatobá-do-cerrado at 0.5 or 1.0 or 1.5 mg/mL, and Simultaneous Treatment (ST) - jatobá-do-cerrado aqueous fraction at a concentration of 0.5 or 1.0 or 1.5 mg/mL associated with paracetamol solution at a concentration of 0.008 mg/mL. All groups were analyzed at 24 and 48 h. Five onion bulbs (five replications) were used for each treatment group. The root tips were fixed in Carnoy and slides prepared by the crush technique. Cells were analyzed throughout the cell cycle, totaling 5,000 for each treatment group at each exposure time. Mitotic indices were subjected to statistical analysis using the chi-square test (p<0.05). From the results it was found that the ST group, at the three concentrations, significantly potentiated the antiproliferative effect of the test system cells when compared to PC, NC and TJ at the three concentrations. Furthermore, the three ST concentrations significantly reduced the number of cell aberrations when compared to the number of aberrant cells obtained for the PC, demonstrating antimutagenic action on the A. cepa test system cells.


Resumo O objetivo do presente trabalho foi avaliar a ação do extrato hidroalcólico do ritidoma de Hymenaea stigonocarpa frente a um composto mutagênico, utilizando como sistema teste as células meristemáticas de raízes de A. cepa. Os grupos tratamentos avaliados foram: Controle Negativo (CN) – água destilada; Controle Positivo (CP) – paracetamol na concentração de 0,008 mg/mL, Controle Jatobá (CJ) – fração aquosa de jatobá-do-cerrado na concentração de 0,5 ou 1,0 ou 1,5 mg/mL, e Tratamento Simultâneo (TS) – fração aquosa de jatobá-do-cerrado na concentração de 0,5 ou 1,0 ou 1,5 mg/mL associada a solução de paracetamol na concentração de 0,008 mg/mL. Todos os grupos foram analisados nos tempos de 24 e 48 h. Para cada grupo tratamento cinco bulbos de cebolas (cinco repetições) foram utilizados. As radículas foram fixadas em Carnoy e as lâminas preparadas pela técnica de esmagamento. Analisaram-se células em todo ciclo celular, totalizando 5.000 para cada grupo tratamento em cada tempo de exposição. Os índices mitóticos obtidos foram submetidos à análise estatística do Qui-quadrado (p<0,05). A partir dos resultados verificou-se que o grupo TS, nas três concentrações, potencializou o efeito antiproliferativo significativo as células do sistema teste quando comparado ao CP, CN e TJ nas três concentrações. Ainda, o TS nas três concentrações reduziu de forma significativa o número de aberrações celulares quando comparado com o número de células aberrantes obtidas para o CP, demonstrando ação antimutagênica as células do sistema teste A. cepa.


Subject(s)
Plant Extracts/pharmacology , Onions/cytology , Onions/physiology , Hymenaea , Acetaminophen/pharmacology , Time Factors , Cell Cycle/drug effects , Meristem , Plant Bark , Antimitotic Agents/pharmacology , Antipyretics/pharmacology , Mitotic Index/methods , Mutagens/metabolism , Mutagens/pharmacology
4.
Korean Journal of Hematology ; : 105-112, 2012.
Article in English | WPRIM | ID: wpr-720205

ABSTRACT

BACKGROUND: Arsenic trioxide (As2O3) is a well-known and effective treatment that can result in clinical remission for patients diagnosed with acute promyelocytic leukemia (APL). The biologic efficacy of As2O3 in APL and solid tumor cells has been explained through its actions on anti-proliferation, anti-angiogenesis, and apoptotic signaling pathways. We theorize that As2O3 activates a pathway that disrupts microtubule dynamics forming abnormal, nonfunctioning mitotic spindles, thus preventing cellular division. In this study, we investigated how As2O3 induces apoptosis by causing microtubule dysfunction. METHODS: Cultured NB4 cells were treated with As2O3, paclitaxel, and vincristine. Flow cytometric analysis was then performed. An MTT assay was used to determine drug-mediated cytotoxicity. For tubulin polymerization assay, each polymerized or soluble tubulin was measured. Microtubule assembly-disassembly was measured using a tubulin polymerization kit. Cellular microtubules were also observed with fluorescence microscopy. RESULTS: As2O3 treatment disrupted tubulin assembly resulting in dysfunctional microtubules that cause death in APL cells. As2O3 markedly enhanced the amount of depolymerized microtubules. The number of microtubule posttranslational modifications on an individual tubulin decreased with As2O3 concentration. Immunocytochemistry revealed changes in the cellular microtubule network and formation of polymerized microtubules in As2O3-treated cells. CONCLUSION: The microtubules alterations found with As2O3 treatment suggest that As2O3 increases the depolymerized forms of tubulin in cells and that this is potentially due to arsenite's negative effects on spindle dynamics.


Subject(s)
Humans , Antimitotic Agents , Apoptosis , Arsenic , Arsenicals , Cell Line , Fluorescence , Immunohistochemistry , Leukemia, Promyelocytic, Acute , Microtubules , Oxides , Paclitaxel , Polymerization , Polymers , Protein Processing, Post-Translational , Tubulin , Vincristine
5.
Rev. cuba. plantas med ; 16(3): 296-303, jul.-set. 2011.
Article in Spanish | LILACS | ID: lil-615732

ABSTRACT

Introducción: Cajanus indicus Spreng (gandul), presenta gran interés terapéutico, sobre todo en la búsqueda de compuestos de origen vegetal que mediante mecanismo antimitótico inhiban el desarrollo de procesos cancerosos. Objetivos: determinar los aspectos agrícolas que proporcionen mayor producción de la parte aérea para su explotación con estos fines. Métodos: durante 2007-2009 se hicieron diferentes investigaciones en la Estación Experimental de Plantas Medicinales Dr. Juan Tomás Roig; en julio de 2007 se realizó un estudio para analizar el comportamiento de la planta y determinar la altura de corte que proporcionara su mejor rebrotación, posteriormente se estudió por 2 años consecutivos, febrero de 2008 hasta febrero de 2009, 2 distancias de siembra: 90 x 30 cm y 90 x 60 cm; y 2 momentos de inicio de cosecha: 3 y 4 meses de edad...


Introduction: Cajanus indicus Spreng. (gandul) is of great therapeutic interest mainly in the search of vegetal compounds capable of inhibiting cancerous processes through the antimycotic mechanism. Objectives: to determine the agricultural aspects that favour higher production of the aerial part of this plant to this end. Methods: in the 2007-2009 period, several research studies were performed in Dr Juan Tomás Roig experimental center of medicinal plants. In July, 2007 a study was conducted to analyze the behaviour of the plant and to determine the cutting height that will encourage the best sprout. From February 2008 to February 2009, 2 sowing distances (90 x 30 cm and 90 x 60 cm) and 2 times of harvest starting (3 and 4 months of age) were studied...


Subject(s)
Antimitotic Agents/analysis , Cajanus , Crops, Agricultural
6.
Bol. latinoam. Caribe plantas med. aromát ; 10(1): 75-82, ene. 2011. ilus, tab
Article in English | LILACS | ID: lil-686902

ABSTRACT

The main objective of anti-carcinogenic chemotherapy is to stop uncontrolled cellular proliferation. This has prompted us to begin a systematic survey of new effective inhibitors with ability to react with cytoskeletal components and arrest living, dividing cells. Even for traditional populations herbs-consuming, encouraging the use of species with chemopreventive actions could be helpful as part of life expectancy improvement strategies. Herbal products have significantly lower costs, exhibit little or no toxicity during long-term oral administration and are relatively available at large scale. Current work involved the screening of 85 extracts from Cuban medicinal plants, selected on the basis of traditional use, ethnobotanics and pharmacological information (antiparasitic, antitumour, abortive, etc.). Antitubulinic activity in the hydroalcoholics extracts was evaluated by using a modified version of the conventional turbidity assay of tubulin assembly/ disassembly. The activity limits of the news isolated antitubulin agents were thoroughly investigated. According to the presented results, the extracts displaying the highest antitubulinic activity were Tamarindus indica L., Lawsonia inermes L and Xanthium strumarium L.


Detener la proliferación celular es el principal propósito de la quimioterapia anticarcinogénica. Para ello se ha realizado una búsqueda a partir de fuentes naturales de nuevos inhibidores efectivos que reaccionen con los componentes del citoesqueleto y puedan detener la división celular. En poblaciones que tradicionalmente utilizan plantas medicinales se estimula el uso de aquellas especies con acción quimiopreventivas como parte de una estrategia que contribuya a la calidad de vida. Los productos herbarios tienen costos significativamente más bajos, exhiben poca o ninguna toxicidad durante la administración oral a largo plazo y están al alcance de todos. Nuestro trabajo consistió en realizar un tamizaje de 85 extractos de plantas medicinales cubanas seleccionadas en base al uso tradicional, en las encuestas etnobotánicas e información farmacológica (actividad antiparasitaria, antitumoral, abortiva, etc). La actividad antitubulínica fue evaluada mediante una versión modificada del ensayo turbimétrico del ensamblaje/desensamblaje de la tubulina. Se determinó la actividad límite de los nuevos agentes antitubulínicos siendo los extractos de Tamarindus indica L., Lawsonia inermes L and Xanthium strumarium L. los de mejor actividad antitubulínica según las condiciones ensayadas.


Subject(s)
Antimitotic Agents/pharmacology , Plant Extracts/pharmacology , Plants/chemistry , Antineoplastic Agents/pharmacology , Cuba , Flora , Lawsonia Plant/chemistry , Microtubules , Plant Preparations/pharmacology , Tamarindus/chemistry , Xanthium/chemistry
7.
Rev. bras. plantas med ; 13(1): 68-72, 2011. tab
Article in Portuguese | LILACS | ID: lil-582764

ABSTRACT

A realização de estudos farmacológicos é fundamental para comprovar a eficácia do uso de plantas medicinais pela população para o tratamento de doenças e descobrir novos fitoterápicos. Esse estudo teve como objetivo avaliar o potencial antimicrobiano do extrato etanólico e fase acetato de etila do bom nome (Maytenus rigida Mart.) sobre Staphylococcus aureus ATCC 25923, 3 amostras de Staphylococcus aureus multirresistentes isoladas de pacientes com infecções nosocomiais, Escherichia coli ATCC 25922, Pseudomonas aeruginosa ATCC 27853 e Salmonella sp. (228-R-Tet, 118-R-Sut e 01-S) isoladas de ambiente aquático, utilizando o método de difusão em agar. Os testes revelaram que o extrato e fase de M. rigida apresentaram atividade antimicrobiana in vitro frente a todas as cepas de S. aureus testadas, apresentando concentração inibitória mínima (MIC) de 400 mg mL-1. Entretanto, estes produtos não apresentaram atividade frente às linhagens de bactérias Gram-negativas testadas, Escherichia coli, Pseudomonas aeruginosa e Salmonella sp.


Ppharmacological studies are essential to prove the effectiveness of using medicinal plants to treat diseases and discover new phytotherapics. This study aimed to evaluate the antimicrobial potential of ethanol and ethyl acetate extracts of "bom-nome" (Maytenus rigida Mart.) against Staphylococcus aureus ATCC 25923, three samples of multiresistant Staphylococcus aureus isolated from patients with nosocomial infections, Escherichia coli ATCC 25922, Pseudomonas aeruginosa ATCC 27853 and Salmonella sp. (228-R-Tet, 118-R-Sut and 01-S) isolated from water environment, using the agar diffusion test. Both extracts showed in vitro antimicrobial activity against all S. aureus strains, presenting 400 mg mL-1 minimum inhibitory concentration (MIC). However, these products did not show activity against strains of the Gram-negative bacteria Escherichia coli, Pseudomonas aeruginosa and Salmonella sp.


Subject(s)
Antimitotic Agents/analysis , In Vitro Techniques , Maytenus , Celastraceae/enzymology , Cross Infection/microbiology , Plants, Medicinal
8.
Rev. bras. plantas med ; 13(2): 183-189, 2011. ilus, tab
Article in Portuguese | LILACS | ID: lil-596392

ABSTRACT

Espécies da família Asteraceae são amplamente utilizadas na medicina popular para diversos fins terapêuticos. Neste contexto, este estudo teve por objetivo averiguar a atividade antimicrobiana e antioxidante in vitro de extratos metanólicos de plantas pertencentes a Asteraceae, a maioria comumente utilizada na medicina tradicional. A prospecção química dos extratos também foi realizada. A atividade antimicrobiana foi avaliada pelo método de susceptibilidade em microdiluição em caldo e a atividade antioxidante determinada pelo ensaio com o radical DPPH. O extrato da folha de Baccharis dracunculifolia apresentou significativa atividade antimicrobiana para Pseudomonas aeruginosa,Bacillus cereus e Cryptococcus neoformans (CIM = 0,005; 0,005 e 0,039 mg mL-1, respectivamente). Os extratos das folhas de Bidens segetum e Matricaria chamomilla foram seletivos para Shigella sonnei e P. aeruginosa (CIM = 0,005 e 0,078 mg mL-1, respectivamente). Já as folhas de Acanthospermun australe e Baccharis trimera apresentaram atividade significativa apenas para Candida albicans (CIM = 0,039 mg mL-1) enquanto as folhas de Taraxacum officinale foram ativos contra ambas leveduras com CIM 0,039 mg mL-1. Em relação à atividade antioxidante, os extratos das folhas de B. dracunculifolia, T. officinale e das inflorescências de B. segetum apresentaram significativa atividade com CI50 de 5, 5 e 4 µg mL-1, respectivamente. A prospecção química dos extratos identificou presença de compostos como flavonoides, terpenos e outros que podem ser responsáveis pelas atividades observadas.


Asteraceae species have been largely used in folk medicine for several therapeutic purposes. Thus, the aim of this work was to investigate the in vitro antimicrobial and antioxidant activities of methanol extracts from plants belonging to the Asteraceae family, most of which are commonly used in traditional medicine. Chemical prospecting of extracts was also performed. The antimicrobial activity was evaluated through the broth microdilution susceptibility method and the antioxidant activity was determined through DPPH assay. Leaf extract of Baccharis dracunculifolia presented a significant antimicrobial activity against Pseudomonas aeruginosa,Bacillus cereus and Cryptococcus neoformans (0.005, 0.005 and 0.039 mg mL-1 MIC, respectively). Leaf extracts of Bidens segetum and Matricaria chamomilla were selective for Shigella sonnei and P. aeruginosa (0.005 and 0.078 mg mL-1 MIC, respectively). On the other hand, Acanthospermun australe and Baccharis trimera leaves only showed significant activity against Candida albicans (0.039 mg mL-1 MIC), while Taraxacum officinale leaves were active against both yeasts, with 0.039 mg mL-1 MIC. As regards antioxidant activity, extracts of B. dracunculifolia and T. officinale leaves and B. segetum inflorescences presented significant activity, with 5, 5 and 4 µg mL-1 IC50, respectively. The chemical prospecting identified the presence of flavonoids, terpenes and other compounds which may be responsible for the observed activities.


Subject(s)
Antimitotic Agents/analysis , Antioxidants/analysis , Asteraceae/chemistry , In Vitro Techniques , Plants, Medicinal , Ethnobotany , Plant Extracts/analysis , Plant Extracts/therapeutic use , Medicine, Traditional
9.
Braz. j. biol ; 70(3): 659-664, Aug. 2010. ilus, tab
Article in English | LILACS | ID: lil-555287

ABSTRACT

Usnic acid, a lichen metabolite, is known to exert antimitotic and antiproliferative activities against normal and malignant human cells. Many chemotherapy agents exert their activities by blocking cell cycle progression, inducing cell death through apoptosis. Microtubules, protein structure involved in the segregation of chromosomes during mitosis, serve as chemotherapeutical targets due to their key role in cellular division as well as apoptosis. The aim of this work was to investigate whether usnic acid affects the formation and/or stabilisation of microtubules by visualising microtubules and determining mitotic indices after treatment. The breast cancer cell line MCF7 and the lung cancer cell line H1299 were treated with usnic acid 29 µM for 24 hours and two positive controls: vincristine (which prevents the formation of microtubules) or taxol (which stabilizes microtubules). Treatment of MCF7 and H1299 cells with usnic acid did not result in any morphological changes in microtubules or increase in the mitotic index. These results suggest that the antineoplastic activity of usnic acid is not related to alterations in the formation and/or stabilisation of microtubules.


O ácido úsnico, um metabólito de liquens, é conhecido por sua atividade antimitótica e antiproliferativa em células humanas normais e malignas. Muitos quimioterápicos exercem suas atividades bloqueando a progressão do ciclo celular e induzindo morte celular por apoptose. Os microtúbulos, estruturas protéicas envolvidas na segregação dos cromossomos durante a mitose, servem como alvo quimioterapêutico devido ao seu importante papel tanto na divisão celular quanto nos mecanismos de morte celular por apoptose. O objetivo deste trabalho foi investigar se o ácido úsnico afeta a formação e/ou estabilização dos microtúbulos, a partir da visualização de microtúbulos e determinação de índices mitóticos após o tratamento. Células de câncer de mama MCF7 e de câncer de pulmão H1299 foram tratadas por 24 horas com 29 µM de ácido úsnico e dois controles positivos: vincristina (que impede a formação de microtúbulos) e taxol (que estabiliza microtúbulos). O tratamento das células MCF7 e H1299 com o ácido úsnico não resultou em aumento do índice mitótico. Os resultados sugerem que a atividade antineoplásica do ácido úsnico não está relacionada a alterações na formação e/ou estabilização de microtúbulos.


Subject(s)
Female , Humans , Antimitotic Agents/pharmacology , Antineoplastic Agents/pharmacology , Benzofurans/pharmacology , Microtubules/drug effects , Paclitaxel/pharmacology , Vincristine/pharmacology , Breast Neoplasms/pathology , Cell Line, Tumor/drug effects , Lung Neoplasms/pathology
10.
Acta cir. bras ; 24(1): 13-18, Jan.-Feb. 2009. ilus, tab
Article in English | LILACS | ID: lil-503099

ABSTRACT

PURPOSE: To evaluate the deposition of collagen fibers at pig's vocal folds after topical use of mitomycin or 5-fluorouracil, when partial exeresis of mucosa layer had been promoted by CO2 laser. METHODS: There were used 18 Larger white pigs which were anesthetized and submitted to mucosa fragment's exeresis, bilaterally, at its free border. The animals were divided into 3 groups, each one with 6 animals: control group, without topical drug application; mitomycin group; and 5-fluorouracil group. After 30 days, the animals were subjected to euthanasia, and samples of the vocal folds were collected and stained by picrosirius red technique with polarization for quantification of total collagen deposition. RESULTS: In control group, the mean rate of right vocal fold's collagen deposition at submucosa consisted in a 3428.66 micrometers area. There was found an area whose size had, in average, 2196.36 micrometers, in mitomycin group, and 2269.19 micrometers, in 5-fluorouracil group. CONCLUSION: Mitomycin and 5-fluorouracil had promoted beneficial change in vocal fold's cicatrization with less collagen deposition, but there was no significant statistically difference when they were compared between themselves.


OBJETIVO: Avaliar a deposição das fibras de colágeno total em pregas vocais suínas após o uso tópico de mitomicina ou 5-fluorouracil nas exéreses parciais de mucosa com laser de CO2. MÉTODOS: Foram utilizados 18 porcos da raça Larger white anestesiados e submetidos à exérese de fragmento de mucosa de borda livre da prega vocal direita e prega vocal esquerda. Os animais foram divididos em 3 grupos com 6 animais cada: grupo controle, sem aplicação de medicação tópica; grupo mitomicina, com uso tópico dessa substância; grupo 5-fluorouracil, uso tópico. Após 30 dias do experimento os animais foram submetidos à eutanásia, coletadas amostras das pregas vocais e coradas pela técnica do picrosirius red com polarização para a quantificação computadorizada da deposição do colágeno total. RESULTADOS: No grupo controle, a média da área do colágeno depositado na submucosa da prega vocal direita foi de 3428,66 micrômetros. No grupo mitomicina a média foi de 2196,36 micrômetros. No grupo 5-fluorouracil, a média foi de 2269,19 micrômetros. CONCLUSÃO: A mitomicina e o 5-fluorouracil promoveram mudança benéfica na cicatrização da prega vocal, com menor deposição de colágeno, porém, quando comparados entre si, eles não apresentaram diferença estatisticamente significante.


Subject(s)
Animals , Female , Male , Antimitotic Agents/administration & dosage , Collagen/analysis , Lasers, Gas , Vocal Cords/surgery , Wound Healing/drug effects , Administration, Topical , Collagen/drug effects , Disease Models, Animal , Drug Evaluation, Preclinical , Fluorouracil/administration & dosage , Mitomycin/administration & dosage , Swine , Vocal Cords/chemistry , Vocal Cords/drug effects
11.
The Korean Journal of Laboratory Medicine ; : 19-21, 2007.
Article in Korean | WPRIM | ID: wpr-35592

ABSTRACT

The inv(16)(p13q22) is found in de novo AML and is closely associated with the FAB subtype M4eo. The inv(16) is rarely reported in therapy-related AML (t-AML) patients. Herein, we report a case of t-AML with inv(16) after combination chemotherapy using antimitotic agent and alkylating agent (cis-platin-paclitaxel) for ovarian serous cystadenocarcinoma.


Subject(s)
Female , Humans , Middle Aged , Antimitotic Agents/adverse effects , Antineoplastic Combined Chemotherapy Protocols/adverse effects , Chromosomes, Human, Pair 16/genetics , Cisplatin/adverse effects , Chromosome Inversion , Leukemia, Myeloid, Acute/chemically induced , Taxoids/adverse effects
12.
Revue Marocaine des Maladies de L'Enfant. 2004; (4): 85-90
in French | IMEMR | ID: emr-68264

Subject(s)
Humans , Antimitotic Agents
13.
Journal of the Korean Ophthalmological Society ; : 94-103, 1999.
Article in Korean | WPRIM | ID: wpr-120425

ABSTRACT

The most common cause of blurred vision after extracapsular cataract extraction is known to be an opacification of the posterior lens capsule. The pathogenesis of posterior lens capsule opacification is primarily caused by residual lens epithelial cells. For the prevention of posterior capsular opacification, several kinds of anti-mitotic drugs is being actively investigated. But the antimitotic drugs are not clinically used due to toxicity towards the intraocular tissues. The objectives of this study is to evaluate the effect of mitomycin C and tirilazad mesylate(FREEDOX(TM)) respectively for inhibiting the proliferation of rabbit lens epithelial cells when it is administered in a short period. Lens epithelial cells from white rabbits were harvested andcultured for 4 passages. Mitomycin C was applied for 3 minutes with 0.025mg/ml and 0.05mg/ml in concentration respectively. The proliferation assay was performed by [(3)H]-thymidine uptake test. Significant decrease of lens epithelial cell proliferation appeared in both drugs.When Mitomycin-C was applied with 0.025mg/ml for 3 minutes, cell proliferation was reduced to 31.5% compared with control and in 0.05mg/ml concentration, to 12.5%. When tirilazad mesylate was applied 0.15mg/ml for 3 minutes, cell proliferation was reduced to 46.5% compared with control and in 1.5mg/ml concentration, to 7.5%. If futher investigation would show the effectives and safety of these drugs, these agents could be applied into the lens capsular bad at the time of surgery to prevent the posterior capsular opacification after cataract surgery.


Subject(s)
Rabbits , Antimetabolites , Antimitotic Agents , Capsule Opacification , Cataract , Cataract Extraction , Cell Proliferation , Epithelial Cells , Mesylates , Mitomycin
14.
Pharmaceutical Journal ; : 6-7, 1999.
Article in Vietnamese | WPRIM | ID: wpr-3707

ABSTRACT

In Vietnam, some medicinal plants have been administrated for cancer treatment. But those medicinal plants have only been used based on experiences and their actual anticancer efficacy have not been proven yet. For that reason, studying to prove anticancer efficacy of those plants is very necessary. In 16 selected medicinal plants had been researched, there were 14 medicinal plants having effect on anti cellular division rate on schizogenous tissue of raphanus sativus L. higher than 50%. They were agave americana L., acanthopanax aculeatus seem, angelica decursiva (Miq) Fr.et Sav., spilanthes acmella (L.) Murr., garcinia cambodgiensis vesque, gleditsia australis hemsl, hippeastrum equestre (Ait.) herb., grium sp. (X2, X3, X4), amarathus tricolor L. and allium sativum L..


Subject(s)
Neoplasms , Plants, Medicinal , Medicine, Traditional , Antimitotic Agents
15.
Pharmaceutical Journal ; : 7-8, 1999.
Article in Vietnamese | WPRIM | ID: wpr-3706

ABSTRACT

Nature has been a source of medical treatments for thousands of years, and plant based systems continue to play an essential role in the primary health care of 80% of the world’ population. Nature has provided many of the effective anticancer agents in current use, such as the microbial derived drugs, dactinomycin, bleomycin, and doxorubicin, and the plant derived drugs vinblastine, irinotecan, topotecan, etoposide and paclitaxel. The search for novel anti-cancer from nature source continues with botanists, marine biologists and microbiologist team-ing up with chemists, pharmacologist, toxicologists and clinicans in the investigation of coral reefs, rain forests, and deep subsurface thermal vents for novel bioactive compounds. The wealth of anticancer drugs of nature origin and critical aspects of the ongoing discovery and development process are discussed.


Subject(s)
Medicine, Traditional , Neoplasms , Antimitotic Agents
SELECTION OF CITATIONS
SEARCH DETAIL